TheEdgeResearch
Home / Stocks / NXTG.TA

Nextage Therapeutics Ltd (NXTG.TA)

TLV Healthcare Drug Manufacturers - Specialty & Generic
$35.50 ▼ -0.84%
Market Cap
$28.8M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.17
52-Wk Range
0.062-89.8
CEO
Orna Dreazen
Country
IL
Currency
ILA

Nextage Therapeutics Ltd operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Ness Ziona, IL. The stock last traded at $35.50, down 0.84% on the session, giving a market capitalisation of $28.8M. Its beta of 0.17 implies it has historically moved less than the broad market.

Company profile
Exchange
Tel Aviv Stock Exchange
Employees
18
IPO date
2002-08-12
Headquarters
Ness Ziona, IL
About Nextage Therapeutics Ltd

Nextage Therapeutics Ltd, a pharmaceutical company, develops cannabinoid-based products in Israel and internationally. The company was incorporated in 1982 and is based in Ness Ziona, Israel.

Comparable companies

Nextage Therapeutics Ltd is most often compared with the following Healthcare names:

AMDA.TABCUR.TACNZN.TACSURE.TAEFNC.TAEMITF-M.TAENDY.TAENVM.TAHUMX.TANXGN.TA
More research on NXTG.TA
NXTG.TA technical analysis NXTG.TA TheEdge Score Compare against peers
Open full interactive analysis & DCF →